Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
All content for UKMFA is the property of Ian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
Dr Liz Evans - Public Child Protection Wales 22nd Feb 2025
UKMFA
14 minutes
9 months ago
Dr Liz Evans - Public Child Protection Wales 22nd Feb 2025
Disclaimer: https://rumble.com/v6056un-ukmfa-disclaimer.html Follow UKMFA on Substack for the best up to date information regarding Medical Ethics, Bodily Autonomy, Informed Consent and Medical Choice: https://substack.com/@ukmfa1 UKMFA CEO, Dr Liz Evans, recorded this short presentation for a conference on 22nd February 2025 organised by Public Child Protection Wales. In it she details the many ways that the State is seeking to involve itself in healthcare decisions for children, cutting par...
UKMFA
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
